Clinical Trial Update: A Study of LY2940094 in Participants With Alcohol Dependency [Phase 2]

View source ↗

Summary

The document notes a Phase 2 study of LY2940094 for alcohol dependence and indicates the trial status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcohol Use Disorder

Drugs mentioned

• LY2940094

Snippet

Sponsor: BlackThorn Therapeutics, Inc. | Conditions: Alcoholism | Phase 2 | Status: COMPLETED